Autolus Therapeutics plc ADR [NASDAQ: AUTL] stock went on a downward path that fall over -5.00% on Monday, amounting to a one-week price decrease of less than -16.67%. Over the last 12 months, AUTL stock rose by 119.65%. The one-year Autolus Therapeutics plc ADR stock
Autolus Therapeutics plc ADR [NASDAQ: AUTL] loss -3.09% on the last trading session, reaching $4.08 price per share at the time. If compared to the average trading volume of 1.55M shares, AUTL reached a trading volume of 3872781 in the most recent trading day, which
Autolus Therapeutics plc ADR [NASDAQ: AUTL] gained 4.01% on the last trading session, reaching $5.70 price per share at the time. The company report on March 14, 2024 at 7:00 AM that Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates. Announced strategic
Autolus Therapeutics plc ADR [NASDAQ: AUTL] stock went on an upward path that rose over 5.84% on Wednesday, amounting to a one-week price increase of more than 14.72%. The company report on February 8, 2024 at 7:00 AM that Autolus Announces Pricing of Underwritten Offering.
Autolus Therapeutics plc ADR [NASDAQ: AUTL] closed the trading session at $6.00. The company report on February 8, 2024 at 7:00 AM that Autolus Announces Pricing of Underwritten Offering. Jefferies LLC and Truist Securities, Inc. are acting as joint bookrunners for the offering. Mizuho Securities
© 2024, Powered by Smart TechOne
